In the last trading session, 1.91 million BioAffinity Technologies Inc (NASDAQ:BIAF) shares changed hands as the company’s beta touched -0.24. With the company’s per share price at $0.70 changed hands at $0.02 or 2.43% during last session, the market valuation stood at $12.78M. BIAF’s last price was a discount, traded about -351.43% off its 52-week high of $3.16. The share price had its 52-week low at $0.24, which suggests the last value was 65.71% up since then. When we look at BioAffinity Technologies Inc’s average trading volume, we note the 10-day average is 57.77 million shares, with the 3-month average coming to 9.53 million.
BioAffinity Technologies Inc (NASDAQ:BIAF) trade information
Instantly BIAF was in green as seen at the end of in last trading. With action 169.23%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -23.08%, with the 5-day performance at 169.23% in the green. However, in the 30-day time frame, BioAffinity Technologies Inc (NASDAQ:BIAF) is 88.43% up. Looking at the short shares, we see there were 0.24 million shares sold at short interest cover period of 1.06 days.
BioAffinity Technologies Inc (BIAF) estimates and forecasts
Year-over-year growth is forecast to reach -35.42% down from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 2.11M. 1 analysts are of the opinion that BioAffinity Technologies Inc’s revenue for the current quarter will be 1.21M. The estimates for the next quarter sales put growth at -49.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -10.71%. The 2025 estimates are for BioAffinity Technologies Inc earnings to increase by 40.00%.
BIAF Dividends
BioAffinity Technologies Inc is expected to release its next quarterly earnings report on 2025-Mar-30.
BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 29.16% of BioAffinity Technologies Inc shares while 3.44% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.85%.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 220.23 shares estimated at $0.15 million under it, the former controlled 1.21% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.25% of the shares, roughly 45.64 shares worth around $31946.0.
